Stocks and Investing Stocks and Investing
Mon, May 13, 2024

Oren Livnat Maintained (TARS) at Strong Buy with Increased Target to $61 on, May 13th, 2024


Published on 2024-10-28 11:17:49 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Maintained "Tarsus Pharmaceuticals, Inc." (TARS) at Strong Buy with Increased Target from $57 to $61 on, May 13th, 2024.

Oren has made no other calls on TARS in the last 4 months.



There are 4 other peers that have a rating on TARS. Out of the 4 peers that are also analyzing TARS, 1 agrees with Oren's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Maintained at Hold with Increased Target to $30 on, Thursday, February 29th, 2024


These are the ratings of the 3 analyists that currently disagree with Oren


  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $60 on, Friday, May 10th, 2024
  • Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $61 on, Thursday, May 9th, 2024
  • Anthony Petrone of "Jefferies" Maintained at Strong Buy with Increased Target to $44 on, Wednesday, March 6th, 2024

Contributing Sources